COVID-19 guidance
NHLBI's Research Strategy
COVID-19 affects all of us, with the heaviest toll on those with preexisting heart, lung, and blood conditions and populations who are vulnerable to these conditions. Our research strategy aims to understand and address risk factors for the disease, develop prevention and treatment strategies, and find ways to hasten and enhance recovery.
Related News
Scientists pinpoint mechanisms associated with severe COVID-19 blood clotting
WHAT: After studying blood samples from 244 patients hospitalized for COVID-19, a group of researchers, including those who work at the National Institutes of Health, identified “rogue antibodies” that correlate with severe illness and may help explain mechanisms associated with severe blood clotting. The researchers found circulating...
Blood pressure up? COVID-19 pandemic could be to blame
It’s a fact few can dispute: The COVID-19 pandemic has been devastating on Americans. It has caused high rates of death and illness, disrupted nearly every aspect of daily life, and been linked to increased heart disease, lung disease, obesity, and sleep problems. Now, NHLBI-funded researchers say the virus and related stress can also be blamed for...
Advancing blood research to help patients recover from COVID-19
NIH research continues to evaluate how blood thinners and anti-inflammatory medications may strengthen recovery at different points in the life of the virus W. Keith Hoots, M.D., director of the Division of Blood Disorders and Resources (DBDR) at the National Heart, Lung, and Blood Institute (NHLBI), shares insight into how treatments that break up...
Unraveling the Mysteries of COVID-19
Severe blood clotting in patients has sent researchers in search of answers to optimize treatment and recovery As the virus that causes COVID-19 invades cells and replicates its code for infection, the body’s immune response fights back. However, for some people this can lead to extreme blood clotting – which can increase the risk for heart attack...
NHLBI’s Strong Heart Study and American Indian communities team up to fight COVID-19
For 33 years, the NHLBI’s Strong Heart Study has focused on learning why American Indians have one of the highest heart disease rates in the nation—almost double that of the general population. And during that time, it has made important discoveries – confirming, for example, that risk factors like diabetes, high blood pressure, and elevated...
NIH Leaders Drs. Gary H. Gibbons and Eliseo J. Pérez-Stable receive prestigious Service to America Medal
Today, the Partnership for Public Service awarded a Samuel J. Heyman Service to America Medal (the Sammies) to Dr. Gary H. Gibbons, director, National Heart, Lung, and Blood Institute (NHLBI) and Dr. Eliseo J. Pérez-Stable, director, National Institute on Minority Health and Health Disparities (NIMHD). The two received the COVID-19 Response medal...
